The “Immuno-Oncology” window is closing, but a massive capital shift toward Cancer
The “Immuno-Oncology” window is closing, but a massive capital shift toward Cancer Neuroscience is creating the next wave of opportunity. […]
The “Immuno-Oncology” window is closing, but a massive capital shift toward Cancer Neuroscience is creating the next wave of opportunity. […]
Jeya Chelliah B.Vsc Ph.D Why do well-designed, innovative proposals still fail before peer review discussion ever begins? The answer increasingly
For decades, the “glucocentric” approach to Type 2 Diabetes has trapped us in a clinical paradox: to lower blood sugar,
You spent years generating the data. You fought for the R01. So why does the final step—sharing your discovery—cost as
How do you target a hostile soldier hiding in a crowd of peacekeepers when they wear the exact same uniform? In
I desperately needed to write. Eighty percent of the way through my Ph.D., with revisions to make and two more
Jeya Chelliah B.Vsc Ph.D In the high-stakes world of life science research, poorly designed experiments can cost weeks of time,
CRISPR Under the Microscope: Detecting and Solving Common Pitfalls in Gene Editing Jeya Chelliah, B.VSc., Ph.D. Introduction: CRISPR – The
Exploring Unique Animal Models for Neurological and Cancer Research A Step-by-Step Guide with LLM Prompts Included Jeya Chelliah, B.VSc., Ph.D
The Mitochondrial Antigen Silencing Switch (MASS) as a Transformative Approach to Prevent Autoimmune Diseases “A New Frontier in Organelle-Level Immune